Literature DB >> 16568289

[Procalcitonin as an early marker of sepsis].

O Thuemer1, E Hüttemann, S G Sakka.   

Abstract

A 64-year-old male with an APC resistance (factor V mutation Leiden) and interrupted oral anticoagulation due to an erosive gastritis, was admitted to hospital for increasing dyspnoea. Transthoracic echocardiography revealed a floating thrombus via an open foramen ovale in both atria reaching both ventricles. Sonography showed multiple stage thrombosis of the left leg reaching to the V. femoralis superficialis. A few months previously, peripheral pulmonary artery embolization has been confirmed by scintigraphy. The patient was transferred to our hospital and underwent emergency surgery for closure of the atrial septum defect and thrombus removal. On the 4th postoperative day, the patient was transferred to the normal ward, however, on the 10th postoperative day, the patient developed a symptomatic transitory psychotic syndrome and became hypotensive before he was transferred to the ICU. Due to impaired oxygenation and the patient's history, a new pulmonary artery embolization was suspected. After ICU admission, the patient required increasing norepinephrine support and rapidly developed septic fever. However, serum procalcitonin was elevated and a computed tomography (skull, chest and abdomen) was performed for a focus search. Pulmonary artery embolism could be ruled out but an oval structure near to the ampulla recti (ca. 30 x 20 mm) was identified as an abscess and immediate abscess incision was performed. After surgery, the further course was characterized by a steep fall in vasopressor support and body temperature. The patient was transferred to the normal ward on the 2nd postoperative day. This case shows that procalcitonin allows early and reliable diagnosis of sepsis in patients with undefined shock.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16568289     DOI: 10.1007/s00101-006-1010-y

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  15 in total

1.  Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial.

Authors:  Mirjam Christ-Crain; Daiana Jaccard-Stolz; Roland Bingisser; Mikael M Gencay; Peter R Huber; Michael Tamm; Beat Müller
Journal:  Lancet       Date:  2004-02-21       Impact factor: 79.321

2.  Sensitivity and specificity of various markers of inflammation for the prediction of tumor necrosis factor-alpha and interleukin-6 in patients with sepsis.

Authors:  M Oberhoffer; W Karzai; A Meier-Hellmann; D Bögel; J Fassbinder; K Reinhart
Journal:  Crit Care Med       Date:  1999-09       Impact factor: 7.598

Review 3.  Biomarkers of sepsis: clinically useful?

Authors:  Michael Meisner
Journal:  Curr Opin Crit Care       Date:  2005-10       Impact factor: 3.687

4.  Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis.

Authors:  S Harbarth; K Holeckova; C Froidevaux; D Pittet; B Ricou; G E Grau; L Vadas; J Pugin
Journal:  Am J Respir Crit Care Med       Date:  2001-08-01       Impact factor: 21.405

Review 5.  [Septic encephalopathy. Diagnosis und therapy].

Authors:  V Eggers; A Schilling; W J Kox; C Spies
Journal:  Anaesthesist       Date:  2003-04       Impact factor: 1.041

6.  Predictive value of procalcitonin and interleukin 6 in critically ill patients with suspected sepsis.

Authors:  Ville Pettilä; Marja Hynninen; Olli Takkunen; Pentti Kuusela; Matti Valtonen
Journal:  Intensive Care Med       Date:  2002-07-19       Impact factor: 17.440

7.  Diagnostic and prognostic value of procalcitonin in patients with septic shock.

Authors:  Christophe Clec'h; Françoise Ferriere; Philippe Karoubi; Jean P Fosse; Michel Cupa; Philippe Hoang; Yves Cohen
Journal:  Crit Care Med       Date:  2004-05       Impact factor: 7.598

Review 8.  D-dimer for the exclusion of acute venous thrombosis and pulmonary embolism: a systematic review.

Authors:  Paul D Stein; Russell D Hull; Kalpesh C Patel; Ronald E Olson; William A Ghali; Rollin Brant; Rita K Biel; Vinay Bharadia; Neeraj K Kalra
Journal:  Ann Intern Med       Date:  2004-04-20       Impact factor: 25.391

9.  Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock.

Authors:  R Phillip Dellinger; Jean M Carlet; Henry Masur; Herwig Gerlach; Thierry Calandra; Jonathan Cohen; Juan Gea-Banacloche; Didier Keh; John C Marshall; Margaret M Parker; Graham Ramsay; Janice L Zimmerman; Jean-Louis Vincent; M M Levy
Journal:  Intensive Care Med       Date:  2004-03-03       Impact factor: 17.440

10.  Usefulness of procalcitonin for diagnosis of sepsis in the intensive care unit.

Authors:  Canan BalcI; Hülya Sungurtekin; Ercan Gürses; Ugur Sungurtekin; Bünyamin Kaptanoglu
Journal:  Crit Care       Date:  2002-10-30       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.